Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$6.47 and traded as low as C$5.68. Fennec Pharmaceuticals shares last traded at C$5.68, with a volume of 970 shares.
Fennec Pharmaceuticals Stock Up 0.2 %
The company has a debt-to-equity ratio of 1,040.68, a current ratio of 8.02 and a quick ratio of 10.17. The firm has a market capitalization of C$155.68 million, a price-to-earnings ratio of 56.90 and a beta of 0.25. The firm's 50-day moving average price is C$6.44 and its 200 day moving average price is C$8.08.
About Fennec Pharmaceuticals
(
Get Free Report)
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
See Also
Before you consider Fennec Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fennec Pharmaceuticals wasn't on the list.
While Fennec Pharmaceuticals currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
